DJIA 17,999.11 -35.82 -0.20%
NASDAQ 5,019.33 24.72 0.50%
S&P 500 2,101.00 0.60 0.03%
market minute promo

XenoPort, Inc. (NASDAQ: XNPT)



company name or ticker

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatmen

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease

Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline

3 Biotech Stocks Under $10 Spiking Higher

August 17th Options Now Available For XenoPort (XNPT)

Does Restless Legs Syndrome Really Shorten Life Span?

A new study suggests a link between this neurological disorder and mortality rates in men.

Mid-Day Update: Benzinga's Top Downgrades

UPDATE: Morgan Stanley Downgrades XenoPort on Recent Failures

Oversold Conditions For XenoPort (XNPT)

This Week in Biotech

Taking a page out of the old West, it was a mix of the good, the bad, and the ugly this week in the biotech sector.

XenoPort Resumes Horizant Supply - Analyst Blog